150 related articles for article (PubMed ID: 28043550)
1. Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience.
Rufai SB; Sankar MM; Singh J; Singh S
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S197-S198. PubMed ID: 28043550
[TBL] [Abstract][Full Text] [Related]
2. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru.
Cáceres O; Rastogi N; Bartra C; Couvin D; Galarza M; Asencios L; Mendoza-Ticona A
PLoS One; 2014; 9(12):e112789. PubMed ID: 25489950
[TBL] [Abstract][Full Text] [Related]
5. Spoligotyping of Mycobacterium tuberculosis isolates at a tertiary care hospital in India.
Suzana S; Shanmugam S; Uma Devi KR; Swarna Latha PN; Michael JS
Trop Med Int Health; 2017 Jun; 22(6):703-707. PubMed ID: 28374900
[TBL] [Abstract][Full Text] [Related]
6. Predominance of Beijing genotype in extensively drug resistant Mycobacterium tuberculosis isolates from a tertiary care hospital in New Delhi, India.
Arora J; Bhalla M; Sidiq Z; Lal P; Behera D; Rastogi N; Myneedu VP
Int J Mycobacteriol; 2013 Jun; 2(2):109-13. PubMed ID: 26785898
[TBL] [Abstract][Full Text] [Related]
7. Genetic Diversity of Mycobacterium tuberculosis Isolates from Assam, India: Dominance of Beijing Family and Discovery of Two New Clades Related to CAS1_Delhi and EAI Family Based on Spoligotyping and MIRU-VNTR Typing.
Devi KR; Bhutia R; Bhowmick S; Mukherjee K; Mahanta J; Narain K
PLoS One; 2015; 10(12):e0145860. PubMed ID: 26701129
[TBL] [Abstract][Full Text] [Related]
8. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
[TBL] [Abstract][Full Text] [Related]
9. 24 loci MIRU-VNTR analysis and pattern of drug resistance in pre-extensively drug resistant pulmonary tuberculosis in Bangladesh.
Monir BB; Sultana SS; Tarafder S
Infect Genet Evol; 2022 Aug; 102():105304. PubMed ID: 35595025
[TBL] [Abstract][Full Text] [Related]
10. Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey.
Khanipour S; Ebrahimzadeh N; Masoumi M; Sakhaei F; Alinezhad F; Safarpour E; Fateh A; Nour Nematollahi A; Hadizadeh Tasbiti A; Zolfaghari MR; Bahrmand AR; Mirsaeidi M; Rahimi Jamnani F; Vaziri F; Siadat SD
J Glob Antimicrob Resist; 2016 Jun; 5():7-10. PubMed ID: 27436458
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority country.
Mokrousov I; Vyazovaya A; Levina K; Gerasimova A; Zhuravlev V; Viiklepp P; Kütt M
Transbound Emerg Dis; 2021 Mar; 68(2):896-906. PubMed ID: 32737943
[TBL] [Abstract][Full Text] [Related]
12. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
13. Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
Mirza IA; Khan FA; Khan KA; Satti L; Ghafoor T; Fayyaz M
J Coll Physicians Surg Pak; 2015 May; 25(5):337-41. PubMed ID: 26008658
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of multidrug-resistant Mycobacterium tuberculosis in Taiwan: a population-based study.
Chang CW; Wu MH; Chuang PC; Jou R
Infect Genet Evol; 2011 Apr; 11(3):633-9. PubMed ID: 21296686
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis - A global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage.
Couvin D; Rastogi N
Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S177-89. PubMed ID: 25797613
[TBL] [Abstract][Full Text] [Related]
16. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
[TBL] [Abstract][Full Text] [Related]
17. Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study.
Cheng S; Hide M; Pheng SH; Kerléguer A; Delvallez G; Sam S; Mao TE; Nguyen TVA; Bañuls AL
Infect Drug Resist; 2021; 14():1089-1104. PubMed ID: 33762833
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China.
Zhao LL; Sun Q; Zeng CY; Chen Y; Zhao B; Liu HC; Xia Q; Zhao XQ; Jiao WW; Li GL; Wan KL
Int J Antimicrob Agents; 2015 Feb; 45(2):137-43. PubMed ID: 25465521
[TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant tuberculosis (XDR-TB) in Morocco.
Ennassiri W; Jaouhari S; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
J Glob Antimicrob Resist; 2017 Dec; 11():75-80. PubMed ID: 28743645
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Diriba G; Kebede A; Tola HH; Yenew B; Moga S; Addise D; Alemu A; Mohammed Z; Getahun M; Fantahun M; Tadesse M; Dagne B; Amare M; Assefa G; Abera D; Desta K
PLoS One; 2020; 15(12):e0243493. PubMed ID: 33284842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
